Exane Derivatives’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $154 | Sell |
12
-2,277
| -99% | -$29.2K | ﹤0.01% | 695 |
|
|
2022
Q1 | $34.9K | Buy |
2,289
+184
| +9% | +$2.81K | 0.01% | 608 |
|
|
2021
Q4 | $37.3K | Buy |
2,105
+2,012
| +2,163% | +$35.6K | 0.01% | 530 |
|
|
2021
Q3 | $1.96K | Sell |
93
-1,095
| -92% | -$23K | ﹤0.01% | 786 |
|
|
2021
Q2 | $25.9K | Sell |
1,188
-5,351
| -82% | -$117K | 0.01% | 676 |
|
|
2021
Q1 | $190K | Buy |
6,539
+720
| +12% | +$20.9K | 0.05% | 300 |
|
|
2020
Q4 | $176K | Buy |
+5,819
| New | +$176K | 0.05% | 320 |
|